Is Big Pharma Hinting At A SMID-Cap Biotech Rally? By: Benzinga via Benzinga February 03, 2016 at 13:16 PM EST UBS analyst Andrew Peters believes investors may be missing a strong bullish sign in the biotech sector this earnings season. According ... Read More >> Related Stocks: AbbVie Bristol-Myers Squibb Gilead Sciences Macy's Pfizer Preferred Securities and Income ETF FT UBS Group Ag ADR